Clinical Trial Update: A Study to Evaluate Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis (IA) or Invasive Mucormycosis (IM) in Pediatric Participants [Phase 2]

View source ↗

Summary

This update reports the results of a Phase 2 pediatric study evaluating isavuconazonium sulfate for invasive aspergillosis and invasive mucormycosis. The trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Aspergillosis
• Invasive Mucormycosis

Drugs mentioned

• Cresemba (isavuconazole)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Invasive Mucormycosis, Invasive Aspergillosis | Phase 2 | Status: COMPLETED | Results posted: 2023-09-21